Full name
APTEKI "CEFARM" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 4,6 | 3,8 | -0,8 | -121,8 |
EBITDA | 0,8 | 1,8 | -0,3 | -114,8 |
Short time liabilities | 17,8 | 18,5 | 20,7 | 12 |
Equity capital | 46,2 | 49,2 | 48,1 | -2,4 |
Operating profit (EBIT) | 0,5 | 1,5 | -0,6 | -141,2 |
Assets | 64,8 | 69,1 | 70,3 | 1,7 |
Net profit (loss) | 5,1 | 3 | -1,2 | -138,8 |
Cash | 0,3 | 0,5 | 0,6 | 21,1 |
Net income from sale | 87,4 | 98,4 | 107,5 | 9,2 |
Liabilities and provisions for liabilities | 18,6 | 19,9 | 22,2 | 11,8 |
Working assets | 27,4 | 32,1 | 37,2 | 15,7 |
Depreciation | 0,4 | 0,4 | 0,3 | -10,9 |
% | % | % | p.p. | |
Profitability of capital | 11 | 6,2 | -2,5 | -8,7 |
Equity capital to total assets | 71,3 | 71,3 | 68,4 | -2,9 |
Gross profit margin | 5,3 | 3,9 | -0,8 | -4,7 |
EBITDA Margin | 0,9 | 1,9 | -0,3 | -2,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 74 | 69 | 70 | 1 |
Current financial liquidity indicator | 1.5278688669204712 | 1.7069969177246094 | 1.7449053525924683 | 0 |
Net dept to EBITDA | -0.34106236696243286 | -0.10916108638048172 | 1.4436312913894653 | 1,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane